Point72 Asset Management’s Theravance Biopharma TBPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $140K | Buy |
+12,692
| New | +$140K | ﹤0.01% | 1222 |
|
|
2022
Q3 | – | Sell |
-105,900
| Closed | -$959K | – | 1360 |
|
|
2022
Q2 | $959K | Sell |
105,900
-550,200
| -84% | -$4.98M | ﹤0.01% | 851 |
|
|
2022
Q1 | $6.27M | Buy |
656,100
+511,000
| +352% | +$4.88M | 0.02% | 587 |
|
|
2021
Q4 | $1.6M | Sell |
145,100
-3,260,502
| -96% | -$36M | 0.01% | 794 |
|
|
2021
Q3 | $25.2M | Buy |
+3,405,602
| New | +$25.2M | 0.11% | 237 |
|
|
2017
Q2 | – | Sell |
-90,700
| Closed | -$3.34M | – | 873 |
|
|
2017
Q1 | $3.34M | Sell |
90,700
-80,000
| -47% | -$2.95M | 0.02% | 542 |
|
|
2016
Q4 | $5.44M | Buy |
+170,700
| New | +$5.44M | 0.04% | 407 |
|